Holston Medical Group participating in worldwide COVID-19 vaccine study
Holston Medical Group is participating in a global study for a COVID-19 vaccine.
The controlled study will enroll around 30,000 adult participants, with half of participants receiving the study vaccine while the other half will receive a placebo. Participants will receive injections over their first two visits, and are asked to keep a diary of symptoms. Four follow-up visits are planned over a two year period to monitor the participant’s health.
The study is sponsored by Pfizer and Biontech.
Those interested locally in enrolling in the study can find out more online or by calling HMG Clinical Research Department in Kingsport at 423-230-2436 or Bristol at 423-274-6367.
More information is available here.
Photo Courtesy: Holston Medical Group